Marex Group Resultados de beneficios anteriores
Pasado controles de criterios 5/6
Marex Group ha aumentado sus beneficios a una tasa media anual de 34.9%, mientras que los beneficios de la industria de Capital Markets han experimentado un crecimiento de 6.1% anual. Los ingresos han ido creciendo a una tasa media de 25.8% al año. La rentabilidad financiera de Marex Group es de 25.8%, y sus márgenes netos son de 10.2%.
Información clave
34.90%
Tasa de crecimiento de los beneficios
38.58%
Tasa de crecimiento del BPA
| Crecimiento de la industria Capital Markets | 10.26% |
| Tasa de crecimiento de los ingresos | 25.76% |
| Rentabilidad financiera | 25.82% |
| Margen neto | 10.22% |
| Última actualización de beneficios | 31 Mar 2026 |
Actualizaciones de resultados anteriores recientes
Recent updates
Seeking Alpha • May 20
Marex Group: Strong Growth, Cheap Valuation, But Still A Volatility-Driven Story
Summary Marex Group plc (MRX) delivered strong Q1 results, with revenues up 48% and adjusted profit before tax up 59%, driven by volatility in energy and metals. MRX's forward P/E of 11.5x and high 22.1% operating margin position it attractively versus peers, despite a cyclical, volatility-dependent business model. Revenue diversification into clearing, securities, and solutions segments reduces reliance on commodities, but future growth remains sensitive to macroeconomic cycles. Key risks include interest rate declines, slower client balance growth, integration of WEBB Traders, and potential operational disruptions from the Bermuda headquarters move. Read the full article on Seeking Alpha
Actualización de narrativa • May 07
MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside
Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Actualización de narrativa • Apr 22
MRX: Higher Fair Value And Lower Future P/E Will Support Upside
Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Actualización de narrativa • Apr 07
MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook
Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.Actualización de narrativa • Mar 24
MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares
Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.Actualización de narrativa • Mar 09
MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside
Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.Actualización de narrativa • Feb 23
MRX: Rising Trading Volumes And Volatility Will Support Earnings Power
Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.Actualización de narrativa • Feb 07
MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward
The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.Actualización de narrativa • Jan 23
MRX: US Expansion And Higher Trading Volumes Will Support Future Upside
Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.Actualización de narrativa • Jan 08
MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim
Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.Actualización de narrativa • Dec 23
MRX Will Benefit From Expanding US Structured Products And Margin Resilience
Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.Actualización de narrativa • Dec 09
MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits
Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.Actualización de narrativa • Nov 25
MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk
Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.Actualización de narrativa • Nov 06
MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits
Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.Actualización de narrativa • Oct 23
Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook
Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.Actualización de narrativa • Oct 08
Digitalization And M&A Will Unlock Global Market Potential
Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).Artículo de análisis • Aug 06
Here's Why Marex Group (NASDAQ:MRX) Has Caught The Eye Of Investors
NasdaqGS:MRX 1 Year Share Price vs Fair Value Explore Marex Group's Fair Values from the Community and select yours...
Nueva narrativa • Apr 27
Acquisitions Will Fuel APAC And Middle East Expansion
Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.Artículo de análisis • Apr 10
Further Upside For Marex Group plc (NASDAQ:MRX) Shares Could Introduce Price Risks After 26% Bounce
Marex Group plc ( NASDAQ:MRX ) shareholders have had their patience rewarded with a 26% share price jump in the last...Artículo de análisis • Dec 25
Many Still Looking Away From Marex Group plc (NASDAQ:MRX)
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...Desglose de ingresos y gastos
Desglose de ingresos y gastos
Cómo gana y gasta dinero Marex Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Mar 26 | 3,266 | 334 | 1,386 | 0 |
| 31 Dec 25 | 2,870 | 294 | 1,250 | 0 |
| 30 Sep 25 | 2,668 | 266 | 1,156 | 0 |
| 30 Jun 25 | 2,608 | 251 | 1,105 | 0 |
| 31 Mar 25 | 2,530 | 234 | 1,052 | 0 |
| 31 Dec 24 | 2,357 | 205 | 990 | 0 |
| 30 Sep 24 | 2,142 | 189 | 939 | 0 |
| 30 Jun 24 | 1,883 | 134 | 1,283 | 0 |
| 31 Mar 24 | 1,849 | 140 | 1,028 | 0 |
| 31 Dec 23 | 1,882 | 128 | 799 | 0 |
| 30 Sep 23 | 1,092 | 140 | 737 | 0 |
| 30 Jun 23 | 1,818 | 139 | 451 | 0 |
| 31 Mar 23 | 1,570 | 115 | 451 | 0 |
| 01 Jan 23 | 1,010 | 92 | 459 | 0 |
| 01 Jan 22 | 825 | 57 | 371 | 0 |
| 31 Dec 20 | 758 | 44 | 277 | 0 |
| 31 Dec 19 | 549 | 36 | 212 | 0 |
| 31 Dec 18 | 384 | 10 | 0 | 0 |
| 31 Dec 17 | 318 | 18 | 0 | 0 |
| 31 Dec 16 | 328 | 20 | 0 | 0 |
| 31 Dec 15 | 346 | 18 | 0 | 0 |
Ingresos de calidad: MRX tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio (10.2%) de MRX son superiores a los del año pasado (9.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: En los últimos 5 años, los beneficios de lMRX han crecido significativamente en un 34.9% al año.
Acelerando crecimiento: El crecimiento de los beneficios de MRX en el último año (42.9%) supera su media de 5 años (34.9% al año).
Beneficios vs. Industria: El crecimiento de los beneficios de MRX en el último año (42.9%) superó al de la industria Capital Markets 37.2%.
Rentabilidad financiera
Alta ROE: Aunque la rentabilidad financiera (25.82%) de MRX es alta, esta métrica está sesgada debido a su elevado nivel de endeudamiento.
Rentabilidad económica
Rendimiento del capital invertido
Descubre empresas con buenos resultados en el pasado
Análisis de la empresa y estado de los datos financieros
| Datos | Última actualización (huso horario UTC) |
|---|---|
| Análisis de la empresa | 2026/05/21 23:56 |
| Precio de las acciones al final del día | 2026/05/21 00:00 |
| Beneficios | 2026/03/31 |
| Ingresos anuales | 2025/12/31 |
Fuentes de datos
Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.
| Paquete | Datos | Marco temporal | Ejemplo Fuente EE.UU. * |
|---|---|---|---|
| Finanzas de la empresa | 10 años |
| |
| Estimaciones del consenso de analistas | +3 años |
|
|
| Precios de mercado | 30 años |
| |
| Propiedad | 10 años |
| |
| Gestión | 10 años |
| |
| Principales avances | 10 años |
|
* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.
A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.
Modelo de análisis y copo de nieve
Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.
Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.
Métricas industriales y sectoriales
Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.
Fuentes analistas
Marex Group plc está cubierta por 13 analistas. 7 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.
| Analista | Institución |
|---|---|
| Benjamin Budish | Barclays |
| Christopher Allen | Citigroup Inc |
| Alexander Blostein | Goldman Sachs |